City

Delft (1)

Groningen (1)

Maastricht (1)

Petach Tikva (1)

Tel Aviv (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Unknown status (1)

Phase

phase 2 (1)

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC (1)

Maastricht Radiation Oncology (1)

Rabin Medical Center (1)

Collaborator

Erasmus Medical Center (1)

HollandPTC (1)

Leiden University Medical Center (1)

Maastro Clinic, The Netherlands (1)

Medical Center Haaglanden (1)

University Medical Center Groningen (1)

Intervention

observational (1)

pembrolizumab (1)

protrait (1)

Study Documents

Intervention Type

other (2)

drug (1)

Funder Type

Other (3)

Study Type

Observational [Patient Registry] (2)

Interventional (1)

Hemangiopericytoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Astrocytoma, Ependymoma, Ganglioglioma Trial in Maastricht, Delft, Groningen (ProTRAIT)

Recruiting

Astrocytoma
+11 more

ProTRAIT

Maastricht, Limburg, Netherlands
+2 more

Apr 12, 2022

Glioma, Glioneuronal Tumor, Choroid Plexus Tumor Trial (Observational)

Not yet recruiting

Glioma
+12 more

Observational

(no location specified)

Feb 17, 2022

Atypical Meningioma, Anaplastic Meningioma, Hemangiopericytoma Trial in Petach Tikva, Tel Aviv (Pembrolizumab)

Unknown status

Atypical Meningioma
+2 more

Pembrolizumab

Petach Tikva, Israel
+1 more

Apr 16, 2019